| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA413: Elbasvir–grazoprevir for treating chronic hepatitis C |
|
Medicine details |
|
| Medicine name | grazoprevir / elbasvir (Zepatier®) |
| Formulation | film-coated tablet |
| Reference number | 2465 |
| Indication | Treatment of chronic hepatitis C in adults |
| Company | Merck Sharp & Dohme Ltd |
| BNF chapter | Infections |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 07/07/2016 |
| NICE guidance | TA413: Elbasvir–grazoprevir for treating chronic hepatitis C |